DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $124,258,856 | +1.0% | 500,841 | -2.3% | 0.50% | +8.1% |
Q2 2023 | $123,041,141 | -7.4% | 512,663 | -2.7% | 0.46% | -10.7% |
Q1 2023 | $132,854,018 | -55.2% | 527,122 | -52.9% | 0.51% | -13.9% |
Q4 2022 | $296,693,978 | +121.2% | 1,120,068 | +115.7% | 0.60% | +0.2% |
Q3 2022 | $134,140,000 | +23.7% | 519,339 | +0.7% | 0.60% | +16.6% |
Q2 2022 | $108,402,000 | -10.1% | 515,902 | +25.5% | 0.51% | -4.1% |
Q1 2022 | $120,635,000 | -19.8% | 411,226 | -10.1% | 0.53% | -15.7% |
Q4 2021 | $150,418,000 | +9.0% | 457,184 | +0.8% | 0.63% | +1.8% |
Q3 2021 | $138,023,000 | +14.6% | 453,373 | +1.0% | 0.62% | +17.4% |
Q2 2021 | $120,418,000 | +15.2% | 448,723 | -3.4% | 0.53% | +17.3% |
Q1 2021 | $104,545,000 | +12.3% | 464,480 | +10.9% | 0.45% | +10.5% |
Q4 2020 | $93,078,000 | +5.2% | 419,014 | +2.0% | 0.41% | -6.0% |
Q3 2020 | $88,474,000 | +20.6% | 410,882 | -1.0% | 0.43% | +10.4% |
Q2 2020 | $73,383,000 | +26.7% | 414,995 | -0.8% | 0.39% | +14.6% |
Q1 2020 | $57,932,000 | -4.6% | 418,551 | +5.8% | 0.34% | +20.4% |
Q4 2019 | $60,736,000 | +5.3% | 395,733 | -0.9% | 0.28% | -1.0% |
Q3 2019 | $57,654,000 | -1.0% | 399,170 | -2.1% | 0.29% | -5.3% |
Q2 2019 | $58,249,000 | +8.7% | 407,564 | +0.4% | 0.30% | +8.6% |
Q1 2019 | $53,595,000 | +30.7% | 405,949 | +2.1% | 0.28% | +19.1% |
Q4 2018 | $41,011,000 | -5.6% | 397,718 | -0.5% | 0.24% | +8.3% |
Q3 2018 | $43,451,000 | +8.8% | 399,884 | -1.2% | 0.22% | +0.9% |
Q2 2018 | $39,925,000 | +2.2% | 404,591 | +1.4% | 0.22% | +2.4% |
Q1 2018 | $39,073,000 | +4.8% | 399,074 | -0.7% | 0.21% | +7.7% |
Q4 2017 | $37,297,000 | +8.5% | 401,834 | +0.3% | 0.20% | +4.8% |
Q3 2017 | $34,368,000 | +0.2% | 400,654 | -1.4% | 0.19% | -7.9% |
Q2 2017 | $34,285,000 | -4.4% | 406,265 | -3.1% | 0.20% | -6.9% |
Q1 2017 | $35,863,000 | +8.8% | 419,299 | -1.0% | 0.22% | +5.9% |
Q4 2016 | $32,960,000 | -3.1% | 423,425 | -2.4% | 0.20% | -5.5% |
Q3 2016 | $34,026,000 | -37.6% | 434,059 | -19.6% | 0.22% | -40.9% |
Q2 2016 | $54,555,000 | +6.6% | 540,151 | +0.2% | 0.37% | +6.1% |
Q1 2016 | $51,156,000 | +2.7% | 539,274 | +0.5% | 0.35% | +4.5% |
Q4 2015 | $49,832,000 | +7.5% | 536,517 | -1.4% | 0.33% | +4.7% |
Q3 2015 | $46,357,000 | +4.1% | 544,012 | +4.6% | 0.32% | +17.5% |
Q2 2015 | $44,516,000 | -0.4% | 520,103 | -1.4% | 0.27% | -3.6% |
Q1 2015 | $44,697,000 | +5.4% | 527,246 | +6.4% | 0.28% | +5.3% |
Q4 2014 | $42,408,000 | +13.6% | 495,468 | +0.6% | 0.26% | +10.4% |
Q3 2014 | $37,327,000 | +327.5% | 492,753 | +344.4% | 0.24% | -34.2% |
Q2 2014 | $8,731,000 | -15.1% | 110,892 | -19.1% | 0.36% | -14.3% |
Q1 2014 | $10,281,000 | +2.9% | 137,071 | +5.9% | 0.43% | +1.9% |
Q4 2013 | $9,990,000 | +14.2% | 129,393 | +2.5% | 0.42% | 0.0% |
Q3 2013 | $8,751,000 | +12.1% | 126,249 | +2.3% | 0.42% | +10.3% |
Q2 2013 | $7,809,000 | – | 123,372 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |